Drawing for FIRECREST

USPTO serial 79105963

FIRECREST

Reviewed by CopyMark Law Group

Reg. 4329839Status 706Registered
Filing date
Status date
Registration date
May 7, 2013
Examiner
HARDY LUDLOW, TARAH KIM
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with FIRECREST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca E. McDougall

Rebecca E. McDougall Morgan, Lewis & Bockius LLP1111 Pennsylvania Avenue, NWAttn: TMSUWashington, DC 20004

Goods and services

ClassDescriptionStatusFirst use
009[ Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signaling, checking supervision and teaching apparatus and instruments, namely, printers; apparatus for recording, transmission or reproduction of sound or images; data processing equipment and computers; computer software for use in website development and management, creation and compilation of spreadsheets, analysis of data, maintenance, distribution and dissemination of data in the field of scientific research, namely, clinical research, clinical studies, clinical trials and clinical treatment, support and guidance in medicine and surgery in the pharmaceutical, biotechnology and medical device fields, including site information and laboratory analysis in the field of pharmaceuticals, biotechnology and medical devices; computer hardware and peripheral devices; computers; laptop computers; tablet computers; computer screens; computer firmware for use in the development, analysis and management of databases in the field of scientific research, namely, clinical research, clinical studies, clinical trials and clinical treatment, support and guidance in medicine and surgery in the pharmaceutical, biotechnology and medical device fields; downloadable electronic publications in the nature of [ scientific papers, ] documents, and reports pertinent to clinical studies, clinical data, clinical research, clinical treatment, support and guidance in medicine and surgery in relation to pharmaceuticals and clinical trials in the fields of pharmaceuticals, biotechnology and medical devices; computer programs for use in preparation of data results, analysis of results, development and delivery of training programs relating to clinical research and analysis; Computer software for use in collating, analyzing data and reporting findings and site management in the fields of chemicals, pharmaceuticals and clinical trials; pre-recorded magnetic data carriers featuring information and data in the field of scientific research, namely, clinical research, clinical studies, clinical trials and clinical treatment, support and guidance in medicine and surgery in the pharmaceutical, biotechnology and medical device fields ]SECTION 71 - CANCELLED—
041Educational services, namely, providing web-based training in the field of clinical studies, clinical data, clinical research, clinical treatment, support and guidance in medicine and surgery, in the pharmaceutical, biotechnology and medical device fields; educational services, namely, training in the field of clinical research and analysis and in the fields of chemicals and pharmaceuticals and the use of information technology in relation to clinical research, analysis, chemicals and pharmaceuticals; [ educational services, namely, conducting and organizing seminars, conferences, symposiums, colloquium and discussion groups in relation to clinical research, analysis, chemicals and pharmaceuticals; ] online and electronic publication of [ scientific papers, ] documents and reports pertinent to a particular study all in connection with clinical studies, clinical data and clinical research in relation to pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fieldsACTIVE—
042[ Scientific research; Scientific and technological services, namely, research and design and laboratory analysis in the field of pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields; Industrial research services in the field of pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields; ] Design and development of [ computer hardware and ] softwareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 11, 2024INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Sep 5, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 4, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 4, 202471AGREGISTERED-SEC.71 ACCEPTED—
Jan 3, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 5, 2023ES71TEAS SECTION 71 RECEIVED—
May 7, 2022REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Oct 24, 2021INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 7, 2021INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 7, 2021INPCINVALIDATION PROCESSED—
Aug 29, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 29, 2020NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Dec 29, 2020C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Dec 16, 2020EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Oct 1, 2020RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 16, 2020PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Apr 9, 2020EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Oct 9, 2019PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Oct 9, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 6, 2019ES75TEAS SECTION 71 & 15 RECEIVED—
Sep 5, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 7, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 24, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 2, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 2, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 30, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 14, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 14, 2013FIMPFINAL DISPOSITION PROCESSED—
Aug 7, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 7, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 10, 2013GPNXNOTIFICATION PROCESSED BY IB—
Feb 19, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 19, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 30, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 30, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 14, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 10, 2013ALIEASSIGNED TO LIE—
Dec 21, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 21, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Dec 21, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 21, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 21, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 21, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Dec 21, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 21, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 21, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 21, 2012CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jun 23, 2012GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 23, 2012GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 23, 2012CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 22, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 21, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 21, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 9, 2012RFNPREFUSAL PROCESSED BY IB—
Dec 21, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 21, 2011RFRRREFUSAL PROCESSED BY MPU—
Dec 20, 2011MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 18, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 17, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2011DOCKASSIGNED TO EXAMINER—
Dec 16, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance